Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33818033)
Watch
English
Effectiveness and tolerability of atomoxetine in a real-world ADHD population: nonrandomized comparison with stimulants
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
title
Effectiveness and tolerability of atomoxetine in a real-world ADHD population: nonrandomized comparison with stimulants
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
main subject
atomoxetine
1 reference
based on heuristic
inferred from title
author name string
Leo Bastiaens
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
publication date
1 December 2007
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
published in
Psychiatry
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
volume
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
issue
12
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
page(s)
44-48
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
cites work
Strattera: ups, downs, and emerging uses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
4 July 2018
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
4 July 2018
Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
4 July 2018
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
4 July 2018
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
4 July 2018
A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
30 October 2018
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
30 October 2018
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
30 October 2018
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861514
retrieved
30 October 2018
Identifiers
PMC publication ID
2861514
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
PubMed publication ID
20436763
1 reference
stated in
Europe PubMed Central
PMC publication ID
2861514
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20436763%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
